SNPX
Synaptogenix, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Alan J. Tuchman MBA(FAAN)
IPO Date
2020-12-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Synaptogenix, Inc.
CEO
Alan J. Tuchman MBA(FAAN)
IPO Date
2020-12-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 800 |
| $2.28 |
| 7 Apr 2025 | Bernstein Bruce | director | A-Award | Acquired | 800 | $2.28 |
| 10 Apr 2024 | SCHECHTER JONATHAN | director | A-Award | Acquired | 800 | $5.39 |
| 10 Apr 2024 | Singer William S. | director | A-Award | Acquired | 800 | $5.39 |
| 10 Apr 2024 | Silverman Joshua | director | A-Award | Acquired | 800 | $5.39 |
| 10 Apr 2024 | Bernstein Bruce | director | A-Award | Acquired | 800 | $5.39 |
| 31 Mar 2023 | SCHECHTER JONATHAN | director | A-Award | Acquired | 20,000 | $0.87 |
| 31 Mar 2023 | Singer William S. | director | A-Award | Acquired | 20,000 | $0.87 |
| 31 Mar 2023 | Silverman Joshua | director | A-Award | Acquired | 20,000 | $0.87 |